Exciting Updates Coming to Marvel Rival Season 3.5: New Blades and Resource Rumble Mode in AugustJuly 31, 2025
Duchenne Therapy Insights: Families Navigating FDA Updates Business July 25, 2025 Jennifer Hill Blair experienced a mix of hope and despair when she learned her son Keise could finally receive a…
Sarepta Stock Dips Following FDA Comments on Elevidys Gene Therapy Business July 18, 2025 Douglas Ingram, CEO of Sarepta Therapeutics, faced challenges at the Forbes Healthcare Summit as the company’s stock plummeted over 30%…
FDA Enhances Transparency by Revealing Comprehensive Response Details Business July 10, 2025 On July 10, 2025, the FDA released over 200 Complete Response Letters (CRLs) concerning drug and biological product applications submitted…
FDA Accelerates AI Innovation with Early Launch of Elsa Tool Business June 4, 2025 The FDA has launched its own generative AI tool named ELSA, aimed at improving operational efficiency while reducing the workload…
Schott Faces FDA Challenges After Support Staff Cuts Business April 19, 2025 The article discusses the impact of substantial job cuts at the Food and Drug Administration (FDA) announced by Health and…
FDA Moves Towards Ending Animal Testing for Monoclonal Antibodies and Other Medications Business April 11, 2025 On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a significant shift in drug development methodology, particularly…
FDA Takes Charge of Avian Flu Response as Veterinarian Funding Faces Sudden Cuts National April 2, 2025 The FDA’s Veterinary Medicine Center (CVM) experienced significant staff cuts, with key personnel overseeing avian flu responses being fired. The…
